β-site APP-cleaving enzyme
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
... proteases: β -site APP- cleaving enzyme (BACE) and ...in APP and the catalytic subunit of γ -secretase, presenilin, cause inherited forms of AD (familial AD (FAD)) with ...
12
The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
... ( β -site APP cleaving enzyme 1) and γ -secretase are important enzymes in this ...of APP and enzymes is essential for APP processing and A β production but several ...
8
β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
... the β-site APP-cleaving enzyme 1 (BACE1, β-secretase) [3] and γ-secretase ...cleaves APP at the first amino acid of the Aβ domain and is crucial for the production of Aβ ...
8
Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
... The APP can be processed through two alternative ...pathway), APP is cleaved by α-sec, which releases the soluble sAPPα N-terminal fragment, creating a membrane-tethered, C-terminal fragment of 83 amino ...
19
Physiochemical features for designing novel B-site APP-cleaving enzyme 1 inhibitor against Alzheimer’s
... Background: Β-site APP-cleaving enzyme 1 (BACE-1) is a target protein for therapeutic treatment of Alzheimer’s disease. Objective: The present work focuses on designing of novel BACE-1 ...
6
Bispecific antibodies and their applications
... ADCC: antibody-dependent cell-mediated cytotoxicity; ADCP: antibody- dependent cellular phagocytosis; ALL: lymphoblastic leukemia; BACE1: β -site APP-cleaving enzyme 1; BiTE: bispecific [r] ...
14
Sorting nexin-4 regulates β-amyloid production by modulating β-site-activating cleavage enzyme-1
... disease; APP: Amyloid precursor protein; A β : β -Amyloid; BACE1: β -Site amyloid precursor protein-cleaving enzyme 1; CTF: C-terminal fragment; EDTA: ...
14
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
... A β : amyloid β peptide; AD: Alzheimer ’ s disease; APH-1: anterior pharynx- defective 1; APP: amyloid β precursor protein; BACE-1: β -site amyloid precursor protein ...
10
Trafficking regulation of proteins in Alzheimer’s disease
... beta-site APP-cleaving enzyme 1 (BACE1) is the dominant β-secetase enzyme for APP ...inhibits APP processing and Aβ generation both in vitro and in vivo ...an ...
13
EXTRACTION AND IN VITRO SCREENING OF POTENTIAL ACETYLCHOLINESTERASE, BUTYRYLCHOLINESTERASE AND BACE1 INHIBITORS FROM THE LEAVES OF OCIMUM SANCTUMRajbongshi Lata, Rahman Azizur, Rahman Mizanur, Howlader Saurav*DOWNLOAD/VIEW
... by β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and γ- secretase ...of APP increased the production and accumulation of neurotoxic forms of Aβ in the ...
8
Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice
... estimated by positron emission computed tomographic imaging using the amyloid-binding [ 11 C]-Pittsburgh compound B (PIB) radioligand [24]. However, as the au- thors of that paper pointed out, a randomised clinical trial ...
12
Cognitive improvement of compound danshen in an Aβ25 35 peptide induced rat model of Alzheimer’s disease
... from APP [23]. BACE1, known as a member of β-secretases, is an important enzyme that cleaved APP to produce ...decreased APP, BACE1 and ...decrease APP mRNA expression in AD ...
9
Demonstration of a deficiency of glucocerebroside cleaving enzyme in Gaucher's disease
... The present observations, coupled with the earlier demonstration that cerebroside synthesis appears normal in Gaucher spleen 8, make it appear quite likely that a deficiency of activity [r] ...
5
Angiotensins and Alzheimer's disease: a bench to bedside overview
... A β (A β 40), as well as to reduce Aβ-mediated toxic effects on rat cells, provided a possible model (that is, ACE can degrade A β ) for ACE involvement in ...A β compared to some shorter A ...
8
Active site protonation states in an Acyl Enzyme intermediate of a Class A β Lactamase with a Monobactam Substrate
...  -lactam antibiotics inhibit bacterial cell wall biosynthesis by targeting penicillin- binding proteins (PBPs). The binding of  -lactam antibiotics to PBPs renders them chemically inert, causing bacterial cell death. ...
8
Cross-talk of membrane lipids and Alzheimer-related proteins
... In addition, there is convincing experimental evidence for the role of membrane lipids not only for the gener- ation of Aβ (see above), but also for their particular role in shifting its conformation from helix to ...
12
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein
... OSBP1, APP, and APP-CTFs expres- sion levels in HEK-APPNFEV, cell monolayers were washed twice with ice-cold PBS and lysed in PBS contain- ing 1% Triton X-100, 1 mM PMSF and Complete protease inhibitor ...
12
Perspectives and applications of immobilised β galactosidase in food industry – a review
... of enzyme activ- ity after immobilisation, leakage and desorption of the biocatalyst from the ...of β -galactosidase ranges from ...immobilised β -galactosidase by adsorption onto bone powder was ...
14
Metformin: an old but still the best treatment for type 2 diabetes
... converting enzyme; AD: Alzheimeir disease; AGE: Advanced glycosilation end product; AMPK: Adenosine monophosfatase protein kinase; BACE 1: Beta-amyloid cleaving enzyme- 1; BMI: Body muscular index; ...
15
Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
... the APP as well [45, 49]; compared to control subjects, NDEVs isolated from AD patients show enrichment of undigested lysosomal APP C-terminal fragments ...
9